Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The duodenal mucosa is the innermost lining of the duodenum—the first segment of the small intestine. It consists primarily of epithelial cells arranged into villi and crypts that maximize surface area for nutrient absorption. Specialized cells within this layer secrete mucus to protect against acidic gastric contents and facilitate digestion by neutralizing stomach acid through Brunner's glands secretions. The lamina propria beneath contains connective tissue and immune cells that contribute to local defense mechanisms. While essential for digestive health and nutrient uptake, it is susceptible to various pathological processes such as inflammation (duodenitis), autoimmune reactions (celiac disease), neoplasia (polyps/cancer), and injury from toxins or medications.
Not applicable—no direct mechanism targeting "duodenal mucosa" as it is not a single molecule/receptor.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Duodenal mucosa.